- Radiopharmaceutical-focused company Lantheus (NASDAQ:LNTH) to acquire Life Molecular Imaging in an all-cash transaction consisting of an upfront payment of $350M and up to an additional $400M in potential earn-out and milestone payments.
- Life Molecular, a subsidiary of Life Healthcare Group Holdings that